5 Banks Bullish on this New Quantum Stock

Quantinuum went public on the Nasdaq one month ago.

The IPO was more than 20 times oversubscribed.

And the stock is already up 38% in its first month of trading.

But the biggest gains didn’t go to the investors who bought the IPO.

Go here for my #1 quantum Pre-IPO.

Quantinuum (Nasdaq: QNT) is the hottest new stock on Wall Street.

5 major banks just initiated coverage and every one of them sees the stock going higher.

JPMorgan has a $97 target…

BofA and Needham both say $100…

Jefferies says $90…

And Rosenblatt is the most bullish of all with a $155 target.

That suggests the stock could jump another 87% from here.

The banks love Quantinuum because it builds both the hardware and the software.

Its newest system has one of the lowest error rates in the industry.

And it already has real customers like JPMorgan, Amgen, and BMW.

The IPO buyers who got in at $60 are up about 38%.

But the investors who got in BEFORE the IPO did far better.

Nvidia’s venture arm invested in Quantinuum’s private funding round last September, at a $10 billion valuation.

Today the company is worth more than $20 billion.

That’s roughly a 100% gain in under a year, simply for getting in before the stock started trading.

That’s the power of Pre-IPO investing.

The biggest gains tend to go to the founding investors, not the IPO crowd.

And right now there’s a new opportunity to do exactly that.

I found a private quantum company I call The Quantum Keystone.

Its technology could be critical to securing banks, digital assets, medical records, and our nation’s infrastructure and defense systems from quantum computing threats.

It’s preparing to open a final Pre-IPO financing before it lists on the Nasdaq or the NYSE.

And there’s a small window to claim Pre-IPO shares for less than $5.

It’s open to every American. You don’t need to be a millionaire or an accredited investor.

My research suggests the stock could jump as much as 300% after IPO day.

Go here now for details – and claim your Pre-IPO shares.

Ian Wyatt

To top